Skip to content
sellWeak cluster of 210b5-1 plan

Harith Rajagopalan sold $206k of GUTS

Chief Executive Officer at FRACTYL HEALTH, INC.. 111,920 shares at an average of $1.84, traded Jan 30, 2025, filed Feb 3, 2025.

Warning score
15
Value
$206k
111,920 shares
Holdings after
491,329
-22% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    CEO
    +25
  • Trade size
    $206k at market
    +12
  • Share of holdings sold
    Sold 22% of holdings
    +5
  • Cluster
    2 insiders selling within 14 days
    +8
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

GUTSOct 9, 2026 · close 4.42
Since filing Feb 3, 2025: -78.3%SPY +32.8% · excess -111.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000950170-25-012531, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jan 30, 2025MOption exercise
Common Stock10b5-1
+20,948$1.70$36k512,277Feb 3, 2025
Jan 30, 2025SOpen-market sale
Common Stock10b5-1
-20,948$1.95$41k491,329Feb 3, 2025
Jan 31, 2025MOption exercise
Common Stock10b5-1
+90,972$1.70$155k582,301Feb 3, 2025
Jan 31, 2025SOpen-market sale
Common Stock10b5-1
-90,972$1.82$165k491,329Feb 3, 2025
Jan 30, 2025MOption exercise
Stock Optionderivative10b5-1
-20,948$0.00$0102,536Feb 3, 2025
Jan 31, 2025MOption exercise
Stock Optionderivative10b5-1
-90,972$0.00$011,564Feb 3, 2025

Related signals

Other insiders at FRACTYL HEALTH, INC. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
31Weak
GUTSbuy
FRACTYL HEALTH, INC.
William Bradley
director
$40k
64,516 shares
+76%
40Moderate
GUTSbuy
FRACTYL HEALTH, INC.
William Bradley
director
$50k
68,493 shares
+425%
33Weak
GUTSbuy
FRACTYL HEALTH, INC.
Harith Rajagopalan
Chief Executive Officer
$20k
10,416 shares
+2%
44Moderate
GUTSbuy 5
FRACTYL HEALTH, INC.
Kelly Ann Barnes
director
$40k
31,000 shares
-
38Weak
GUTSbuy 5
FRACTYL HEALTH, INC.
Ajay Royan
director, owner
$23k
17,901 shares
-
38Weak
GUTSbuy 5
FRACTYL HEALTH, INC.
William Bradley
director
$20k
16,129 shares
-
38Weak
GUTSbuy 5
FRACTYL HEALTH, INC.
Samuel Conaway
director
$9,964
8,550 shares
-
38Weak
GUTSbuy 5
FRACTYL HEALTH, INC.
Amy W Schulman
director
$9,964
8,550 shares
-
12Weak
GUTSsell 210b5-1
FRACTYL HEALTH, INC.
Jay David Caplan
President, Chief Product Off.
$82k
43,818 shares
-25%
34Weak
GUTSsell 2
FRACTYL HEALTH, INC.
Jay David Caplan
President, Chief Product Off.
$159k
64,197 shares
-29%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Harith Rajagopalan sold $206k of GUTS | InsiderTell